Kuwajima S, Noda T, Izumi Y, Kitao H, Naka K, Okuda K
Yaenosato Hospital, Osaka.
Rinsho Byori. 1992 Jul;40(7):751-5.
Early in this century, trypsin inhibiting activity has already been recognized in patients with acute infection or renal disease. In addition to these, conditions such as coronary thrombosis, surgical operation, artificial fever by heat-killed bacilli, malignancy, leukemia, later stage of normal pregnancy, etc. have been known to cause the elevated excretion of UTI in urine. Typically, maximal excretion of UTI has been observed within one or two days after the onset. It appears that recent studies have overcome the complexity of UTI molecule. Automated measurement of urinary trypsin inhibitor (UTI) in urine sample was carried out by either enzymic or immunologic method. UTI as well as erythrocyte sedimentation rate and C-reactive protein enables us to monitor acute phase response, being confirmed in cases of abdominal surgery.
本世纪初,急性感染或肾病患者体内已被发现存在胰蛋白酶抑制活性。除此之外,诸如冠状动脉血栓形成、外科手术、热灭活杆菌引起的人工发热、恶性肿瘤、白血病、正常妊娠后期等情况也已知会导致尿液中尿胰蛋白酶抑制剂(UTI)排泄增加。通常,在发病后的一两天内可观察到UTI的最大排泄量。近期的研究似乎已克服了UTI分子的复杂性。通过酶法或免疫法对尿液样本中的尿胰蛋白酶抑制剂(UTI)进行自动测量。UTI以及红细胞沉降率和C反应蛋白使我们能够监测急性期反应,这在腹部手术病例中得到了证实。